iBio, Inc. News, iBio, Inc. Quote, IBIO Quote

iBio, Inc. (NQ:IBIO) Delayed: 1.62 -0.03 (1.82%)

Prev. Close

$1.65

Today 6M 1Y 5Y

Open

$1.68

52 Wk High

$0.80

52 Wk Low

$0.34

Day High

$1.69

Day Low

$1.62

P/E

N/A

EPS

$-0.08

Volume

398,856

Friends, Peers and Foes (?): LLY, MTSR NVO (more...)

ALERTS | RSS

Jun 8, 2026 06:07 AM Raymond James Starts iBio, Inc. (IBIO) at Outperform
Jun 5, 2026 08:36 AM B.Riley Starts iBio, Inc. (IBIO) at Buy
Jun 2, 2026 04:01 PM iBio to Participate in Upcoming Healthcare Investor Conferences
Jun 2, 2026 07:00 AM iBio begins phase 1 trial of obesity drug IBIO-600
Jun 2, 2026 07:00 AM iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
May 19, 2026 07:45 AM Form 4 iBio, Inc. For: May 18 Filed by: Stoner Elizabeth
May 15, 2026 06:42 PM Form SCHEDULE 13G/A iBio, Inc. Filed by: Logos Global Management LP
May 15, 2026 04:27 PM Form SCHEDULE 13G/A iBio, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 02:26 PM Form SCHEDULE 13G/A iBio, Inc. Filed by: EcoR1 Capital, LLC
May 15, 2026 01:22 PM Form SCHEDULE 13G/A iBio, Inc. Filed by: Cormorant Asset Management, LP

Entities mentioned with IBIO

View All Entities